CooperCompanies to Participate in the KeyBanc Life Sciences MedTech Investor Forum
March 02 2021 - 4:15PM
CooperCompanies (NYSE: COO), will participate in the KeyBanc Life
Sciences MedTech Investor Forum on Wednesday, March 24, 2021. Brian
Andrews, Executive Vice President, Chief Financial Officer &
Treasurer, will represent the Company in a virtual session
scheduled to begin at 1:15PM ET.
A live webcast of the Company’s session will be available on the
Investor Relations section of CooperCompanies’ website at
http://investor.coopercos.com. An archived audio file will be
available for replay on the same webpage later in the day.
About CooperCompaniesCooperCompanies ("Cooper")
is a global medical device company publicly traded on the NYSE
(NYSE:COO). Cooper operates through two business units,
CooperVision and CooperSurgical. CooperVision brings a refreshing
perspective on vision care with a commitment to developing a wide
range of high-quality products for contact lens wearers and
providing focused practitioner support. CooperSurgical is committed
to advancing the health of women, babies and families with its
diversified portfolio of products and services focusing on medical
devices and fertility & genomics. Headquartered in San Ramon,
CA, Cooper has a workforce of more than 12,000 with products sold
in over 100 countries. For more information, please visit
www.coopercos.com.
Contact:
Kim DuncanVice President, Investor Relations and Risk
Management925-460-3663ir@cooperco.com
Cooper Companies (NYSE:COO)
Historical Stock Chart
From Mar 2024 to Apr 2024
Cooper Companies (NYSE:COO)
Historical Stock Chart
From Apr 2023 to Apr 2024